Please login to the form below

Not currently logged in
Email:
Password:

The New England Journal of Medicine

This page shows the latest The New England Journal of Medicine news and features for those working in and with pharma, biotech and healthcare.

Roche’s Xofluza issued FDA approval to treat influenza in children aged five years and older

Roche’s Xofluza issued FDA approval to treat influenza in children aged five years and older

The results were published in The Pediatric Infectious Disease Journal and The New England Journal of Medicine, respectively. ... The results showed that Xofluza was well tolerated with no new safety signals identified.

Latest news

More from news
Approximately 1 fully matching, plus 182 partially matching documents found.

Latest Intelligence

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    This data was peer-reviewed and published in the New England Journal of Medicine. ... The data was peer-reviewed and published in the Journal of the American Medical Association (JAMA).

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    In an article published by The New England Journal of Medicine, Nicole Lurie, Melanie Saville, Richard Hatchett and Jane Halton from the CEPI urged caution: ‘Vaccine development is a lengthy, expensive ... That includes possible changes to ongoing

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    As confirmed cases of the novel coronavirus worldwide surge over 939, 436 (as of 2 April), all eyes are firmly set on the pharmaceutical and life sciences industries for the development ... Although the data, published in The New England Journal of

  • Is anybody listening? Is anybody listening?

    Evidence-based listening. The evidence-base is growing. A study published in the Journal of Medical Internet Research shows how ‘social ties’ formed in online spaces provide the basis for both ... A recent study in the New England Journal of Medicine

  • The Heart of the Matter 2 - How is social media impacting publication planning? The Heart of the Matter 2 - How is social media impacting publication planning?

    In the medical mainstream, one of the best examples of how far social media activity has come is provided by the New England Journal of Medicine. ... The journal’s deft use of social media has seen it gain more than a million 'Likes' on Facebook, aided

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Improving healthcare for rare disease patients Improving healthcare for rare disease patients

    The pilot study, published in the New England Journal of Medicine in 2021,. ... Accessed March 1, 2022. NHS England. NHS England announces new Innovative Medicines Fund to fast-track promising new drugs.

  • Barber shops provide a short cut to BP reduction

    The basics of preventive medicine are cut and dried: don't smoke, eat less, drink less, exercise more, and reduce your risk factors for life-limiting illnesses like cardiovascular disease, diabetes ... The study, published in the New England Journal of

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...